Blocking buffers and reagents are essential in IHC protocols to minimize nonspecific antibody binding and reduce background staining. These steps are critical for ensuring specific, high-contrast staining of target antigens.
Purpose of Blocking
- Reduce Nonspecific Binding: Antibodies can bind non-target proteins or charged/hydrophobic sites within tissue, causing background staining.
- Improve Signal-to-Noise Ratio: Blocking saturates these nonspecific sites, ensuring that antibody binding is primarily directed to the antigen of interest.
- Prevent Cross-Reactivity: Especially important in tissues rich in Fc receptors or endogenous biotin.
Types of Blocking Buffers and Reagents
| Blocking Reagent | Main Components | When to Use | Key Benefits |
|---|---|---|---|
| Normal Sera | Goat, donkey, mouse, etc. | Before primary antibody; match secondary host | Blocks Fc receptors, reduces cross-reactivity |
| Protein Block Solutions | BSA, casein, gelatin | Standard protocols, animal-free applications | Coats nonspecific sites, animal-free options |
| Animal-Free Blocking Solutions | Synthetic or plant proteins | Sensitive/cross-reactive samples | No animal proteins, reduces cross-reactivity |
| Avidin/Biotin Blocking Kits | Avidin, biotin | With avidin-biotin detection systems | Blocks endogenous biotin, prevents background |
Proper selection and application of blocking buffers and reagents are fundamental for achieving specific, high-quality IHC results with minimal background staining.
Practical Considerations
- Order of Application: Blocking is performed after quenching endogenous enzymes but before primary antibody incubation.
- Optimization: The choice and concentration of blocking reagent should be optimized for each tissue and antibody to avoid masking epitopes or insufficient blocking.
- Washing: Always wash well after blocking to remove excess proteins or reagents that might interfere with antibody binding.